Hims & Hers Health, Inc.

Overview

Hims & Hers Health, Inc. is a consumer-focused digital healthcare company offering online access to healthcare professionals, prescriptions, pharmacy fulfillment, and personalized care. Its services cover areas including sexual health, hair loss, weight loss, dermatology, hormone health, and mental health. The company’s stated mission is “to help the world feel great through the power of better health”; it launched in 2017.[1][2] Its reported operating geographies include the United States, United Kingdom, Canada, Germany, Ireland, France, Spain, Australia, and Japan.[3]

The company reported revenue of $753.2 million for the quarter ended June 30, 2026, and full-year 2025 revenue of $2.348 billion.[4][5] Its 2025 Form 10-K reported 2,442 employees as of December 31, 2025.[6] [1]+5

Products & services

Hims & Hers offers prescription treatments for sexual health, hair loss, hormone health, weight loss, dermatology and mental health. Customers can be evaluated by licensed clinicians, who may prescribe treatment; prescriptions are then fulfilled through licensed pharmacies. Its platform supports provider consultations, electronic medical records and prescriptions, and pharmacy fulfillment. The company also sells over-the-counter drugs and devices, cosmetics and supplements, including products for skincare, sexual wellness, general wellness and hair care.[2][7]

For weight loss, the company offers access to branded GLP-1 medicines, including eligible customers’ access to Novo Nordisk’s FDA-approved Wegovy pill; its Q2 2026 filing describes a shift toward branded GLP-1 access in the U.S. and limited-scale compounded GLP-1 offerings. Weight-loss membership services include care-team support and nutrition, exercise and in-app weight-tracking features. Other service capabilities include laboratory testing, wellness content, educational programs and community support.[8]+4

Subscriptions offer recurring treatment or product shipments, with terms varying by offering. The company does not disclose revenue by individual product or treatment category in the cited reporting. It reported that the Hers brand accounted for over 40% of U.S. revenue in Q2 2026, with growth driven primarily by weight-loss and dermatology offerings; a majority of U.S. revenue in Q2 and the first half of 2026 came from non-GLP-1 offerings.[13][14] [2]+10

Geographic presence

Hims & Hers Health, Inc. reported operations in the United States, United Kingdom, Australia, Japan, Canada, and the European Union, specifically Germany, Ireland, France, and Spain, as of its second-quarter 2026 filing [15]. Its international footprint expanded through acquisitions, including Eucalyptus in June 2026 and Zava in July 2025 [16]. The company announced its launch in Australia on August 31, 2026, describing it as its first expansion into the Asia-Pacific market [17].

For the six months ended June 30, 2026, reported revenue was $1,151.739 million in the United States and $209.579 million in the Rest of the World, out of $1,361.318 million total—approximately 84.6% and 15.4%, respectively [18]. The company reports geography as United States and Rest of the World rather than breaking out revenue by individual foreign country [18].

The principal executive office is at 2269 Chestnut Street, #523, San Francisco, California 94123 [19]. At year-end 2025, the company reported leased offices, fulfillment centers, and other facilities in the United States, the United Kingdom, the European Union, and Canada [20]. Its workforce was largely remote, with exceptions for fulfillment and certain facility roles and some international employees; the company did not provide geographic employee counts [20]. [15]+8

Business segments

Hims & Hers Health, Inc. reports one operating and reportable segment, managed on a consolidated basis; it does not report separate segments by product or geography. Its platform provides access to treatments and services across areas including sexual health, hair loss, hormone health, weight loss, dermatology, mental health, and laboratory testing. These are business focus areas, not separately reported segments.[21][7]

For FY2025, U.S. revenue was approximately 94.3% of total revenue, with non-U.S. revenue accounting for the remaining 5.7%; these geographic figures are revenue-mix indicators, not segment contributions. The company also reported that personalized offerings generated over 70% of U.S. revenue and the Hers brand nearly 40%; these overlapping measures likewise are not segment shares.[22][23] [21]+3

Company history

Hims launched in 2017, founded by Andrew Dudum, Hilary Coles, Jack Abraham, and Joe Spector. The company expanded to women’s health with the launch of its Hers brand in 2018.[24]+2

In 2020, Hims & Hers agreed to go public through a merger with Oaktree Acquisition Corp.; the transaction closed in January 2021, and the company began trading on the New York Stock Exchange as HIMS. In 2021, it expanded its dermatology and international operations through acquisitions of Apostrophe and Honest Health, and added individual online therapy to its mental-health services.[27]+4

The company launched a weight-loss program in 2023 and added access to injectable GLP-1 treatments in 2024. In 2025, it broadened its women’s-health services with menopause and perimenopause care and expanded internationally, including entry into Canada. In 2026, it completed its acquisition of Eucalyptus and entered Australia, extending its operations into the Asia-Pacific region.[32]+5 [24]+13

Sources

• Hims & Hers Health, Inc. — Full financial report (2026 Q 2)
  11 citations

  [1][3][4][8][9][10][14][15][16][18][19]
• Hims & Hers Health, Inc. — Full financial report (2025 Y)
  8 citations

  [2][5][7][13][20][21][22][23]
• www.sec.gov[6]
• investors.hims.com[11]
• www.forhers.com[12]
• investors.hims.com[17]
• Hims & Hers Health, Inc. — Full financial report (2024 Y)[24]
• investors.hims.com[25]
• techcrunch.com[26]
• investors.hims.com[27]
• investors.hims.com[28]
• investors.hims.com[29]
• investors.hims.com[30]
• investors.hims.com[31]
• investors.hims.com[32]
• investors.hims.com[33]
• investors.hims.com[34]
• investors.hims.com[35]
• investors.hims.com[36]